NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

About this update from Nugen Medical Devices Inc

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is providing a summary of key developments achieved during 2025 across its Research and Development programs, technical capabilities, clinical initiatives, and global commercial activities. 2025 Operational Highlights Research & Development Technical & Engineering Capacity Clinical & Medical Engagement Commercial & Market Activity "Our progress in 2025 reflects the disciplined work of our teams across R&D, clinical development, and global market engagement," said Liang Lin, CEO of NuGen Medical Devices Inc. "The advancements made this year strengthen our foundation and support the continued evolution of our needle-free technology." About NuGen Medical Devices NuGen develops next-generation needle-free devices for subcutaneous drug delivery. Its flagship InsuJet™ system is approved in 42 countries and is designed to improve the lives of millions of people with diabetes worldwide. Websites: insujet.com | insujet.fr | nugenmd.com LinkedIn: https://www.linkedin.com/company/nugen-medical-devices Investor Relations: [email protected] For further information, please contact:Liang Lin, Chief Executive Officer+ [email protected] Notice Regarding Forward-Looking Information: Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accept responsibility for the adequacy or accuracy of this release. This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", &...

View stock analysis, news, and events for Nugen Medical Devices Inc